9-Aug-21 - First patient dosed
+9 months
27-May-22 - 6th patient dosed (trial advances to P2)
+5-8 months
Q4-22 - 10th patient dosed (Borje's options vest)
+7-9 months
7-Jul-23 - 20th patient dosed
"Given the strategic intent of the Company to migrate from RC110 to RC220, and with the full endorsement of Professor Nagler, it has been agreed that the RI-002 protocol will recruit the final two patients and then proceed to report on outcomes over the coming months.
...The Chaim Sheba investigational team is now working towards assembling the data for publication in a peer-reviewed journal followed by a report to the market on the study outcomes."
They were recruiting >1 patient a month once they hit P2 (probably easy to recruit given interim results detailed in ASH publication). Should have long recruited the final 2 patients.
T believes it to be commercially negligent releasing the Cardio MOA - could feel the same about any validation of CPACS / FTO inhibition. IMO holders should be fully informed of all matters CPACS/FTO prior to the expiry of the bonus options - whether that's detrimental to the future IP value or otherwise.
General Comments / Chat, page-10409
-
-
- There are more pages in this discussion • 959 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
|
|||||
Last
$1.79 |
Change
0.090(5.29%) |
Mkt cap ! $289.6M |
Open | High | Low | Value | Volume |
$1.76 | $1.79 | $1.76 | $125.3K | 70.87K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 6674 | $1.77 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.79 | 991 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 6674 | 1.765 |
3 | 21528 | 1.755 |
1 | 10000 | 1.750 |
1 | 744 | 1.735 |
1 | 8714 | 1.720 |
Price($) | Vol. | No. |
---|---|---|
1.790 | 991 | 1 |
1.795 | 9921 | 4 |
1.800 | 2071 | 5 |
1.805 | 783 | 1 |
1.815 | 1325 | 1 |
Last trade - 10.42am 02/09/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, MD & CEO
Anthony Noble
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online